Home

Alivus Life Sciences Ltd Quarterly Result

Image

Alivus Life Sciences Ltd

NSE: ALIVUS

Net Profit - Last Quarter

₹ 136.96 Cr.

Last updated on: Feb 05, 2025

Alivus Life Sciences Ltd Quarterly Results Key Highlights

  • The revenue of Alivus Life Sciences Ltd for the Dec '24 is ₹ 652.3 crore as compare to the Sep '24 revenue of ₹ 515.41 crore.
  • This represent the growth of 26.56%a1# The ebitda of Alivus Life Sciences Ltd for the Dec '24 is ₹ 200.76 crore as compare to the Sep '24 ebitda of ₹ 142.89 crore.
  • This represent the growth of 40.5%a1# The net profit of Alivus Life Sciences Ltd for the Dec '24 is ₹ 136.96 crore as compare to the Sep '24 net profit of ₹ 95.32 crore.
  • This represent the growth of 43.68%a1#.

Alivus Life Sciences Ltd Quarterly Results Analysis

Market Price of Alivus Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Alivus Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Feb 20251226.65
04 Feb 20251215.4
03 Feb 20251175.05
01 Feb 20251154.6
31 Jan 20251202
30 Jan 20251168.3
29 Jan 20251158.4
28 Jan 20251156.85
27 Jan 20251197.35
24 Jan 20251151.35

Historical Revenue of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Alivus Life Sciences Ltd

No data available

* All values are in crore

Alivus Life Sciences Ltd News Hub

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth

Read more

05 Aug 24

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o

Read more

06 Sept 24

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.

Read more

25 Oct 24

Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe

Read more

25 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Alivus Life Sciences Ltd

What key financial metrics are included in Alivus Life Sciences Ltd's quarterly results?

Key financial metrics in Alivus Life Sciences Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Alivus Life Sciences Ltd announce its quarterly results?

Alivus Life Sciences Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Alivus Life Sciences Ltd's quarterly performance impact its stock price?

Alivus Life Sciences Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Alivus Life Sciences Ltd's quarterly results on dividends?

The impact of Alivus Life Sciences Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Alivus Life Sciences Ltd's quarterly results?

Yes, Alivus Life Sciences Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions